The FDA has granted two new endometrial cancer indications to rival immunotherapies: Merck’s Keytruda and AstraZeneca’s Imfinzi.
On Monday, regulators
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Cerceo is an academic hospitalist and environmental health advocate. As hospitalists, our scope of practice is rapidly expanding. No longer can we be content addressing
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus right now, but our spirits
Even in adults without hypertension, blood pressure readings may climb more steeply over the years as the number of daily alcoholic drinks rise, according to